Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salivary Oxytocin as a Biomarker of Psychedelic Assisted Psychotherapy in Patients With Major Depressive Disorder

NCT07345858 is registered in ClinicalTrials.gov with University of Geneva, Switzerland as lead sponsor.

NCT NCT07345858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07345858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salivary Oxytocin as a Biomarker of Psychedelic Assisted Psychotherapy in Patients With Major Depressive Disorder
Lead sponsor
University of Geneva, Switzerland
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 5, 2026
Completion date
October 30, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)